Skip to main content
. 2012 Jun 21;2012:584262. doi: 10.1155/2012/584262

Table 4.

Conditions for which macrolide use may be beneficial, primarily as a result of their anti-inflammatory, immunomodulatory activity.

(i) Diffuse panbronchiolitis
(ii) Cystic fibrosis (CF)
(iii) Non-CF bronchiectasis
(iv) Bronchiolitis obliterans
(v) Chronic obstructive pulmonary disease
(vi) Asthma
(vii) Pneumonia